Clinical Trial Characteristics of Cardiovascular disease:
Cardiovascular disease is the leading cause of death globally. According to the “China Cardiovascular Disease Report 2018”, the current prevalenceof cardiovascular disease in China is 290 million. Unhealthy diet, smoking, drinking, lack of exercise, and other unhealthy habits have led to a sustained increase in the incidence of cardiovascular disease in China. It was estimated that 2 of every 5 deaths resulted from Cardiovascular disease, ranking the first among all diseases. From an epidemiological point of view, cardiovascular drugs are still an important area focused on public health. Global cardiovascular drug research and development is facing great challenges,but the market and R&D prospects remain very promising.
Advantages of Tigermed:
Patient-focused clinical trial staff, extensive domestic and international clinical trial experience, and good cooperation with experts in the cardiovascular field are highlighted by Tigermed’s clients for selecting us as their partner of choice.Besides these criteria, the wide range of hospitals and patient centers to cooperate with are what sets us apart from other CROs. Also, we have a specific focus onthe indications hypertension and hyperlipidemia.
Our clinical trial experience includes but is not limited to the following cardiovascular diseases:
? Essential hypertension
? Chronic heart failure
? Arrhythmias (ventricular premature beats, atrial fibrillation, etc.)
? Coronary heart disease (acute coronary syndrome, stable angina, etc.)
Project ExperienceThe cardiovascular team is managed by 6 medical directors and 10 project managers that have an average working experience of 7 years.